TAUTOMERIC PHENOMENON OF FK506 IN SOLUTION

被引:0
|
作者
NAMIKI, Y [1 ]
KIHARA, N [1 ]
FUJIOKA, M [1 ]
SHIMATANI, K [1 ]
FUJIWARA, A [1 ]
HANE, K [1 ]
YASUDA, T [1 ]
机构
[1] FUJISAWA PHARMACEUT CO LTD,ANALYT RES LABS,OSAKA 532,JAPAN
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1992年 / 203卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:72 / ANYL
相关论文
共 50 条
  • [31] ORAL ABSORPTION OF FK506 IN RATS
    KAGAYAMA, A
    TANIMOTO, S
    FUJISAKI, J
    KAIBARA, A
    OHARA, K
    IWASAKI, K
    HIRANO, Y
    HATA, T
    PHARMACEUTICAL RESEARCH, 1993, 10 (10) : 1446 - 1450
  • [32] FK506与心脏移植
    孟旭
    陈宝田
    中华胸心血管外科杂志, 1998, (02) : 58 - 60
  • [33] Behavioral assessment of neuroprotection by FK506
    Marston, HM
    Sharkey, J
    IMMUNOPHILINS IN THE BRAIN: FKBP LIGANDS: NOVEL STRATEGIES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, 2000, : 173 - 182
  • [34] 肾移植与FK506
    周吉海,谭季春
    日本医学介绍, 1994, (06) : 269 - 270
  • [35] Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506
    Kotaka, Masayo
    Ye, Hong
    Alag, Reema
    Hu, Guangan
    Bozdech, Zbynek
    Preiser, Peter Rainer
    Yoon, Ho Sup
    Lescar, Julien
    BIOCHEMISTRY, 2008, 47 (22) : 5951 - 5961
  • [36] INTERACTION BETWEEN FK506 AND ERYTHROMYCIN
    SHAEFFER, MS
    COLLIER, D
    SORRELL, MF
    ANNALS OF PHARMACOTHERAPY, 1994, 28 (02) : 280 - 281
  • [37] COMPARATIVE STUDIES OF FK506 WITH CYCLOSPORINE
    HEWITT, CW
    BLACK, KS
    TRANSPLANTATION, 1988, 46 (03) : 482 - 483
  • [38] MODEL FOR PREDICTION OF FK506 DOSING
    STEINMULLER, DR
    FITZSIMMONS, WE
    SELF, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 181 - 181
  • [39] FK506的肾毒性
    祖强
    姚冰
    于立新
    肾脏病与透析肾移植杂志, 2000, (03) : 251 - 253
  • [40] PANCREATICODUODENAL ALLOTRANSPLANTATION WITH CYCLOSPORINE AND FK506
    SATO, K
    YAMAGISHI, K
    NAKAYAMA, Y
    YOKOTA, K
    UCHIDA, H
    MASAKI, Y
    WATANABE, K
    ASO, K
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1074 - 1075